| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | STEADYMED LTD | 28,758 | 94,000 | 0.04% | ||
| 2 | NEOVASC INC | 262,060 | 135,000 | 0.06% | ||
| 3 | ADMA BIOLOGICS, INC. | 36,500 | 217,000 | 0.09% | ||
| 4 | OCERA THERAPEUTICS INC | 131,000 | 249,000 | 0.11% | ||
| 5 | IMMUNOMEDICS INCORPORATED | 116,743 | 271,000 | 0.12% | ||
| 6 | NEURODERM LTD | 24,683 | 401,000 | 0.17% | ||
| 7 | ADAMIS PHARMACEUTICALS CORP | 155,500 | 435,000 | 0.18% | ||
| 8 | Aldeyra Therapeutics Inc | 77,500 | 441,000 | 0.19% | ||
| 9 | ZOGENIX INC | 58,750 | 473,000 | 0.20% | ||
| 10 | FIVE PRIME THERAPEUTICS INC | 13,250 | 548,000 | 0.23% | ||
| 11 | INOTEK PHARMACEUTICALS CORP | 75,000 | 558,000 | 0.24% | ||
| 12 | TONIX PHARMACEUTICALS HOLDING | 284,877 | 567,000 | 0.24% | ||
| 13 | FOAMIX PHARMACEUTICALS LTD | 102,000 | 648,000 | 0.28% | ||
| 14 | ALLIQUA BIOMEDICAL INC | 583,026 | 653,000 | 0.28% | ||
| 15 | WRIGHT MED GROUP N V | 586,936 | 740,000 | 0.31% | ||
| 16 | OPHTHOTECH CORP | 25,000 | 1,276,000 | 0.54% | Call | |
| 17 | Intersect ENT Inc | 100,000 | 1,293,000 | 0.55% | Call | |
| 18 | SYNERGY PHARMACEUTICALS DEL | 350,000 | 1,330,000 | 0.57% | ||
| 19 | FLEX PHARMA INC COM | 142,000 | 1,450,000 | 0.62% | ||
| 20 | NUVASIVE INC | 25,000 | 1,493,000 | 0.63% | ||
| 21 | VIVEVE MED INC COM NEW | 368,919 | 1,513,000 | 0.64% | ||
| 22 | INVACARE CORP COM | 125,000 | 1,517,000 | 0.64% | Call | |
| 23 | ATRICURE INC | 110,098 | 1,556,000 | 0.66% | ||
| 24 | GW PHARMACEUTICALS PLC | 18,000 | 1,648,000 | 0.70% | Call | |
| 25 | ALLERGAN PLC | 7,920 | 1,830,000 | 0.78% | ||
| 26 | KITE PHARMA INCORPORATED | 37,250 | 1,863,000 | 0.79% | ||
| 27 | AVEXIS INC COM | 50,800 | 1,931,000 | 0.82% | ||
| 28 | AKORN INCORPORATED | 71,000 | 2,022,000 | 0.86% | ||
| 29 | VARIAN MED SYS INC | 25,000 | 2,056,000 | 0.87% | Put | |
| 30 | MEDIVATION INC | 36,250 | 2,186,000 | 0.93% | ||
| 31 | HILL ROM HLDGS INC | 45,000 | 2,270,000 | 0.96% | ||
| 32 | SIENTRA INC | 350,000 | 2,303,000 | 0.98% | ||
| 33 | AMARIN CORP PLC | 1,087,500 | 2,349,000 | 1.00% | ||
| 34 | ENDOLOGIX INC | 205,000 | 2,554,000 | 1.09% | ||
| 35 | CARDIOVASCULAR SYS INC DEL COM | 145,289 | 2,670,000 | 1.13% | ||
| 36 | OPHTHOTECH CORP | 52,500 | 2,679,000 | 1.14% | ||
| 37 | Intersect ENT Inc | 215,000 | 2,780,000 | 1.18% | ||
| 38 | CYNOSURE CL A ORD | 60,000 | 2,919,000 | 1.24% | ||
| 39 | DEPHEID | 95,000 | 2,921,000 | 1.24% | ||
| 40 | JAZZ PHARMACEUTICALS PLC | 22,000 | 3,109,000 | 1.32% | ||
| 41 | SPECTRANETICS CORP | 175,000 | 3,274,000 | 1.39% | ||
| 42 | CYNAPSUS THERAPEUTICS INC | 200,845 | 3,364,000 | 1.43% | ||
| 43 | INVACARE CORP COM | 292,500 | 3,548,000 | 1.51% | ||
| 44 | THERMO FISHER SCIENTIFIC INC | 25,000 | 3,694,000 | 1.57% | Put | |
| 45 | CVS HEALTH CORP | 40,000 | 3,830,000 | 1.63% | ||
| 46 | Wright Medical Group NV | 225,000 | 3,908,000 | 1.66% | ||
| 47 | ABBOTT LABS | 100,000 | 3,931,000 | 1.67% | ||
| 48 | CELGENE CORP | 41,875 | 4,130,000 | 1.76% | ||
| 49 | ATHENA HEALTH INC. | 30,000 | 4,140,000 | 1.76% | ||
| 50 | PFIZER INC | 117,675 | 4,143,000 | 1.76% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-012350, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
